Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Lapatinib | 3.1623 | uM | 8 | 312.50 | 129.17 | 287.00 | 202.25 | 1.4190 | 2.4355 |
| BT-20 | 17-AAG | 0.31623 | uM | 8 | 312.50 | 129.17 | 112.00 | 202.25 | 0.5538 | -0.1978 |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 224.00 | 202.25 | 1.1075 | 1.3421 | |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 149.00 | 202.25 | 0.7367 | 0.2471 | |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 166.00 | 202.25 | 0.8208 | 0.4738 | |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 162.00 | 202.25 | 0.8010 | 0.4192 | |
| BT-20 | Linsitinib | 1 | uM | 8 | 312.50 | 129.17 | 178.00 | 202.25 | 0.8801 | 0.6417 |
| BT-20 | Erlotinib | 0.31623 | uM | 8 | 312.50 | 129.17 | 245.00 | 202.25 | 1.2114 | 1.6901 |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 225.00 | 202.25 | 1.1125 | 1.3583 | |
| BT-20 | Linsitinib | 19.9526 | uM | 8 | 312.50 | 129.17 | 156.00 | 202.25 | 0.7713 | 0.3388 |
| BT-20 | Linsitinib | 0.0033113 | uM | 8 | 312.50 | 129.17 | 223.00 | 202.25 | 1.1026 | 1.3259 |
| BT-20 | Erlotinib | 10 | uM | 8 | 312.50 | 129.17 | 218.00 | 202.25 | 1.0779 | 1.2458 |
| BT-20 | Erlotinib | 3.1623 | uM | 8 | 312.50 | 129.17 | 324.00 | 202.25 | 1.6020 | 3.1437 |
| BT-20 | 17-AAG | 0.0031623 | uM | 8 | 312.50 | 129.17 | 198.00 | 202.25 | 0.9790 | 0.9354 |
| BT-20 | Erlotinib | 0.01 | uM | 8 | 312.50 | 129.17 | 236.00 | 202.25 | 1.1669 | 1.5388 |
| BT-20 | Linsitinib | 0.01 | uM | 8 | 312.50 | 129.17 | 267.00 | 202.25 | 1.3201 | 2.0725 |
| BT-20 | 17-AAG | 0.0001 | uM | 8 | 312.50 | 129.17 | 268.00 | 202.25 | 1.3251 | 2.0903 |
| BT-20 | 17-AAG | 0.01 | uM | 8 | 312.50 | 129.17 | 131.00 | 202.25 | 0.6477 | 0.0220 |
| BT-20 | Linsitinib | 10 | uM | 8 | 312.50 | 129.17 | 227.00 | 202.25 | 1.1224 | 1.3907 |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 294.00 | 202.25 | 1.4536 | 2.5658 | |
| BT-20 | Lapatinib | 1 | uM | 8 | 312.50 | 129.17 | 228.00 | 202.25 | 1.1273 | 1.4070 |
| BT-20 | Lapatinib | 10 | uM | 8 | 312.50 | 129.17 | 66.00 | 202.25 | 0.3263 | -0.6458 |
| BT-20 | Lapatinib | 0.0033113 | uM | 8 | 312.50 | 129.17 | 255.00 | 202.25 | 1.2608 | 1.8617 |
| BT-20 | Linsitinib | 0.1 | uM | 8 | 312.50 | 129.17 | 294.00 | 202.25 | 1.4536 | 2.5658 |
| BT-20 | Lapatinib | 0.031623 | uM | 8 | 312.50 | 129.17 | 229.00 | 202.25 | 1.1323 | 1.4234 |